Prof Walt Besio’s medical device company brings new technology to diagnose and treat brain disorders to market. CREmedical’s tripolar electrode sets a new standard in brain sensing and neuromodulation.
What: Extremely sensitive, non-invasive brain monitoring and neuromodulation built on strong IP.
Innovation: Revolutionary medical device will reduce costs and risk to epilepsy patients by controlling and treating seizures non-invasively.
Who: URI Biomedical Engineering professor and Ryan Neuroscience Institute co-founder Walt Besio (Biomedical Engineering)
Market: Epilepsy detection and treatment
Idea: Device detects new biomarkers and safely stimulates specific brain areas for treatment. By conducting electricity into and out of specific brain areas, the therapy device pinpoints areas to treat epilepsy.
Notes: Awarded NSF SBIR II grant – Slater Technology investment 2017